home / stock / ambs / ambs news

AMBS News and Press, Amarantus BioScience Holdings Inc From 03/17/20

Stock Information
Company Name: Amarantus BioScience Holdings Inc
Stock Symbol: AMBS
Market: OTC
Website: amarantus.com
Menu
AMBS AMBS Quote AMBS Short AMBS News AMBS Articles AMBS Message Board
Get AMBS Alerts

News, Short Squeeze, Breakout and More Instantly...
AMBS - Todos Medical and 3DMed Enter Into Coronavirus (COVID-19) and Influenza A/B Testing Kit Distribution Agreement in US and Israel

  3DMed test demonstrated 99.3% sensitivity and 100% specificity in Chinese clinical trial   Nucleic Acid test performed on proprietary automated platform to increase throughput   CE Mark and China FDA approval have been received; 3DMed in discussions with US FDA and...
AMBS - UPDATE: Todos Medical Enters Into Coronavirus Nucleic Acid Buccal Testing Kit Distribution Agreement With 3D BioMed

3D BioMed test demonstrated 99.3% sensitivity and 100% specificity in Chinese clinical trial  Nucleic Acid test performed on proprietary automated platform to increase throughput  CE Mark and Chinese FDA approval have been received; 3D BioMed in discussions with US FDA  T...

AMBS - Todos Medical Announces Legacy Convertible Note Extension, Lock-Up Agreements, and New Debt Financing

REHOVOT, Israel, Feb. 25, 2020 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro-diagnostics company focused on the development of blood tests for the early detection of cancer and neurodegenerative disorders, today announced it has entered into convertible no...

AMBS - Todos Medical Receives Notice of Allowance from European Patent Office Covering Diagnosis of Solid Tumors Using AI to Analyze Blood

REHOVOT, Israel, Feb. 19, 2020 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro-diagnostics company focused on the development of blood tests for the early detection of cancer and neurodegenerative disorders, today announced that it has received a notice of a...
AMBS - Todos Medical Releases Letter to Shareholders

REHOVOT, Israel, Feb. 07, 2020 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro-diagnostics company focused on the development of blood tests for the early detection of cancer and neurodegenerative disorders, today released a letter to shareholders: Dear S...

AMBS - Amarantus Announces Subsidiary MANF Therapeutics Enters Into Material Transfer Agreement with Dyadic International

New York, NY, Feb. 06, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE --   Amarantus Bioscience Holdings, Inc. (OTC Pink: AMBS) (“Amarantus,” or AMBS), a biotechnology holding company pursuing proprietary therapeutics and diagnostics, as well as CBD Wellness through its subs...

AMBS - Amarantus Acquires Majority Interest in CBD Wellness Company Hempori

  Strong customer retention at both stores in Dallas, TX with growing online presence   Focus  on delivering wellness solutions by engaging customers to participate in clinical studies and provide outcomes data to determine utility of branded CBD products   ...
AMBS - Todos Medical Enters into Exclusive Option Agreement to Acquire Provista Diagnostics and Announces Management Changes

REHOVOT, Israel, Jan. 09, 2020 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro-diagnostics company focused on the development of blood tests for the early detection of cancer and neurodegenerative disorders, today announced that it has entered into an exclus...

AMBS - Amarantus Completes Sublicense of ESS, MANF and PhenoGuard to Emerald Organic Products

  Emerald gains exclusive worldwide development rights to ESS, MANF and PhenoGuard   Amarantus receives Emerald preferred stock valued at a minimum of $66.6 million New York, NY, Jan. 02, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE --  Amarantus Bioscience Holdings,...

AMBS - Amarantus to Present at 12th Annual LD Micro Main Event

NEW YORK, NY, Dec. 09, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Amarantus Bioscience Holdings, Inc. (OTC Pink: AMBS) (the “Company,” or AMBS), a US-based JLABS-alumnus biotechnology holding company, developing first-in-class orphan neurologic, regenerative medicine a...
Previous 10 Next 10